Valeant reports profit in fourth quarter on $1.3 billion tax benefit

(Reuters) - Valeant Pharmaceuticals on Wednesday reported a profit in the fourth quarter compared to a year-earlier loss, as it booked a one-time benefit because of new U.S. tax laws.

from Reuters: Business News http://ift.tt/2FekcuV